Article
Pulmonary Inflammation Home Visit Case Study in Australia
November 18, 2021
This case study reviews Labcorp MCS support of a global pulmonary inflammation clinical trial that was active in Australia, highlighting the benefits on a global level and the specific challenges faced in the Pacific country.